Actualités Actualités Actualités

Actualités

Portefeuille

Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)

19/09/2024 - 17:45

Portfolio

ImCheck Receives FDA Fast Track Designation for ICT01 in Combination with Azacitidine and Venetoclax in First-Line Acute Myeloid Leukemia for Patients Unfit for Induction Chemotherapy Treatment

18/09/2024 - 11:38

Portfolio

ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base

17/09/2024 - 17:01

Portfolio

Biotalys granted patents for EVOCA in both Europe and the US

17/09/2024 - 07:00

Portefeuille

Gimv cède sa participation dans Mega International à Bizzdesign, ce nouvel ensemble formant un leader dans le domaine de l'architecture d'entreprise et de la transformation numérique

05/09/2024 - 07:30

Corporate

Trading update

03/09/2024 - 07:00

Portfolio

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

02/09/2024 - 09:12

Portefeuille

ImCheck obtient 20,18 millions d’euros de financement public dans le cadre du plan France 2030

29/08/2024 - 14:11

Portfolio

Biotalys Named Sustainable Crop Protection Company of the Year

21/08/2024 - 09:31

Portfolio

Industry expert Roland Türk begins as new CEO of Techinfra GmbH

02/08/2024 - 13:46

Corporate

Report of the Extraordinary General Shareholders’ Meeting

31/07/2024 - 17:45

Portefeuille

Projective Group expands its payments strategy expertise with the acquisition of Thede Consulting

26/07/2024 - 11:39

Contact médias

Investor Relations Investor Relations Investor Relations

Investor Relations

Avez-vous des questions ou vous désiriez obtenir plus d'informations?
N'hésitez pas à nous contacter.